Localized prostate cancer detection with 18F FACBC PET/CT: comparison with MR imaging and histopathologic analysis - Wikidata - wikimedia - TriplyDB

Localized prostate cancer detection with 18F FACBC PET/CT: comparison with MR imaging and histopathologic analysis

Localized prostate cancer detection with 18F FACBC PET/CT: comparison with MR imaging and histopathologic analysis

http://www.wikidata.org/entity/Q34681143

about

A Review of Imaging Methods for Prostate Cancer Detection.PET Metabolic Biomarkers for Cancer Imaging tumor metabolism using positron emission tomography Positron emission tomography (PET) in primary prostate cancer staging and risk assessment Anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid: physiologic uptake patterns, incidental findings, and variants that may simulate disease.[(18)F](2S,4S)-4-(3-Fluoropropyl)glutamine as a tumor imaging agent.Recurrent prostate cancer detection with anti-3-[(18)F]FACBC PET/CT: comparison with CT.The value of anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid PET/CT in the diagnosis of recurrent prostate carcinoma: a meta-analysis.Novel Imaging of Prostate Cancer with MRI, MRI/US, and PET.Prostate Cancer Imaging with Novel PET Tracers.PET imaging of recurrent and metastatic prostate cancer with novel tracers.Imaging of local recurrence in prostate cancer.Diagnostic performance and safety of NMK36 (trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid)-PET/CT in primary prostate cancer: multicenter Phase IIb clinical trial.PET Tracers Beyond FDG in Prostate Cancer.Advances in Prostate Cancer Magnetic Resonance Imaging and Positron Emission Tomography-Computed Tomography for Staging and Radiotherapy Treatment Planning.Advances in medical imaging for the diagnosis and management of common genitourinary cancers.Multimodal Imaging in Focal Therapy Planning and Assessment in Primary Prostate Cancer.⁸⁹Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer.Diagnostic Performance and Safety of Positron Emission Tomography Using 18F-Fluciclovine in Patients with Clinically Suspected High- or Low-grade Gliomas: A Multicenter Phase IIb Trial.[Focus on molecular imaging in prostate cancer].Phase IIa Clinical Trial of Trans-1-Amino-3-(18)F-Fluoro-Cyclobutane Carboxylic Acid in Metastatic Prostate Cancer.Multimodality imaging using proton magnetic resonance spectroscopic imaging and 18F-fluorodeoxyglucose-positron emission tomography in local prostate cancer.Multisite Experience of the Safety, Detection Rate and Diagnostic Performance of Fluciclovine (18F) Positron Emission Tomography/Computerized Tomography Imaging in the Staging of Biochemically Recurrent Prostate Cancer ¹⁸F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer.11C-Choline PET/pathology image coregistration in primary localized prostate cancer.Molecular imaging and fusion targeted biopsy of the prostate.A PET/MRI study towards finding the optimal [18F]Fluciclovine PET protocol for detection and characterisation of primary prostate cancer.Phase IIa clinical study of [18F]fluciclovine: efficacy and safety of a new PET tracer for brain tumors.The use of PET/CT in prostate cancer.Prospective evaluation of 18F-FACBC PET/CT and PET/MRI versus multiparametric MRI in intermediate- to high-risk prostate cancer patients (FLUCIPRO trial).18F-DCFBC Prostate-Specific Membrane Antigen-Targeted PET/CT Imaging in Localized Prostate Cancer: Correlation With Multiparametric MRI and Histopathology.Molecular imaging of prostate cancer.Positron emission tomography in prostate cancer: An update on state of the art Role of PET imaging for biochemical recurrence following primary treatment for prostate cancer Clinical implications of PET/CT in prostate cancer management

P2860

Q26766398-C85CB681-AF6F-4526-AECE-6483253B3D6E Q28074449-22771759-BB43-49AA-94F5-EA3E6C4A8723 Q28085278-3A1CBC27-7831-4173-85DC-9E7C8C5505A7 Q33890153-27F1482F-E973-4633-87FC-4CE296308AD2 Q34451031-35C78BBA-E8F1-4636-94D3-79DD4D0F6564 Q34473613-B19F846C-FF9A-4F08-86EF-C8A0B7185FD7 Q34522627-77685725-8917-488D-A04A-49F3A156DF4D Q38439189-367CC1C6-CB6C-4A91-A731-2B05B45E8ED7 Q38606252-9BCD4354-FD39-46FB-908C-AF14A35DB5E8 Q38732369-3A66846B-EB77-4F55-A6D5-52DA818E5376 Q38831029-181D0BCD-A090-493C-BE97-87003FA42F9D Q38852724-6DCE7055-9DD6-457C-9CF7-B2889099124A Q38924532-853A0D1B-6905-4FC2-8D6E-441FA9417C43 Q39003086-A9B8EAA2-C160-445A-9218-765A20F6D3FB Q39041614-42033806-83E3-4BF9-925B-DB897D4EF209 Q39307896-CAB6F09A-DE41-4817-8559-7E51EE378F14 Q39438297-33BC1ABC-1958-470D-ABE2-0611816D54B3 Q39828822-311A5009-03B7-4EB8-8FAF-E68D417FEE02 Q41026634-3344A3A2-BDDF-4B4F-BFA9-7C964C06C82D Q41585395-6F2EA52E-C04F-4A6E-B798-F397A6C4D030 Q41862609-502F3CF1-5582-4142-BD04-C2AD04E44721 Q42371983-EB44464C-097C-4F67-9D60-1642C9199300 Q42379563-3A6E7887-4FFB-4991-9EAF-79D30A16A4EB Q43156292-C981C6F1-36D1-4AF7-B3EF-2F8651851C56 Q45797636-086E6EA5-6F18-4FA9-8528-A869483DDF39 Q47608215-76F329B1-53CE-445F-B046-A3E389BD20B2 Q48243611-961CEBFB-8164-4AF9-B843-F7F2C699A530 Q48457964-BCB41F99-564E-4207-ADEF-3C8739350D99 Q49919217-BC19DBA0-DBE9-4770-BF65-318D79699C3A Q49939705-286CFFC3-36F8-4293-9251-7C0B13A68472 Q50430295-2EF91A35-F1E4-4A1C-ADEC-BACCC555B7FC Q52411549-17E73C4E-8F38-4191-B1E9-1AA63E36DD87 Q57110351-75D67F78-8A53-4E91-81C5-66B828130F69 Q58562169-D3477A53-46C9-4119-B907-607A273D92D3 Q59137133-F92647AE-4070-4F75-8DB2-4F6D21B1DB04

P2860

Localized prostate cancer detection with 18F FACBC PET/CT: comparison with MR imaging and histopathologic analysis

http://www.wikidata.org/entity/Q34681143

description

2013 nî lūn-bûn

@nan

2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Localized prostate cancer dete ...... g and histopathologic analysis

@ast

Localized prostate cancer dete ...... g and histopathologic analysis

@en

Localized prostate cancer dete ...... g and histopathologic analysis

@nl

type

label

Localized prostate cancer dete ...... g and histopathologic analysis

@ast

Localized prostate cancer dete ...... g and histopathologic analysis

@en

Localized prostate cancer dete ...... g and histopathologic analysis

@nl

prefLabel

Localized prostate cancer dete ...... g and histopathologic analysis

@ast

Localized prostate cancer dete ...... g and histopathologic analysis

@en

Localized prostate cancer dete ...... g and histopathologic analysis

@nl

P1433

Q34681143-EA39F67D-DABE-4053-BA92-14F34E6166B4

P1476

Q34681143-BAE95969-A597-4FB1-9E54-58CBB621F4BB

P2093

Q34681143-1544BB86-1ED2-4D87-87BB-4833285B11C1

Q34681143-2EF386ED-AB43-4729-B481-40462D23810D

Q34681143-526F6B67-4811-429A-A9EC-157FE20DC968

Q34681143-54E2E57C-5F80-47D5-8BE0-82E6A36415A4

Q34681143-73D54192-63EC-4A85-AFF1-52480ACF57F7

Q34681143-904D1AB2-109E-4428-A28A-8DBE3E2A40FB

Q34681143-A653CE86-913E-49CE-A76B-1F2D90B0BCAC

Q34681143-B26C97AF-CC59-4C76-A3A7-3E5B57016108

Q34681143-C4B3A3FF-A63B-4F16-BFD3-F694FBCD2C01

Q34681143-CF7075B0-F771-4D09-9753-ACDAF9E91614

P2860

Q34681143-0142BF01-3375-4EAA-9152-095D137F88B0

Q34681143-086FC435-E561-4DC5-8C7B-4730C8C04A61

Q34681143-1C826490-5640-448C-927F-45221C8E2900

Q34681143-28DD2C44-238D-4978-BDAB-BA486EEDCC45

Q34681143-29E666D3-C46D-4BF8-986A-D74198812650

Q34681143-2D9E4D97-495E-4B23-BF4B-25A986F9681D

Q34681143-302173DC-C1BC-46D5-8735-39BE50A94154

Q34681143-406000EA-91BA-4D82-94E2-052FCA3F11A4

Q34681143-468A787F-839D-4DCB-A32C-683C575E5AB7

Q34681143-5F9C9FB2-97F7-4E1C-A0E8-DB017663E40B

P304

Q34681143-CAF70D3B-7A9F-4ABD-BBD5-7FD239B42060

P31

Q34681143-C27ABD7A-8A6B-44A2-86A9-2E2E49B84942

P356

Q34681143-649D6930-69D8-4278-AC50-D7163E11AE11

P407

Q34681143-33C68D82-AD16-4534-839E-7B327ACFFEC5

P433

Q34681143-E23A74B0-BA72-4C7E-8BA5-3894615082A9

P478

Q34681143-3BBB534A-336A-4BC7-94B5-4401D4D50375

P50

Q34681143-EAE6349A-3311-4071-A1EE-756F741B0549

P577

Q34681143-E732C5E8-BD74-40B7-83DC-0AD6E62E12CB

P5875

Q34681143-CBB06AF8-6903-4310-84FA-55757AC2895E

P698

Q34681143-EA3C79E1-A916-49CD-BBCB-E1F6B9353E6B

P932

Q34681143-5D69489C-C5BF-4A1B-95FD-229AF35E2E2E

P356

RADIOL.13130240

P1433

P1476

Localized prostate cancer dete ...... g and histopathologic analysis

@en

P2093

Baris Turkbey

http://www.w3.org/2001/XMLSchema#string

Esther Mena

http://www.w3.org/2001/XMLSchema#string

Joanna Shih

http://www.w3.org/2001/XMLSchema#string

Marcelino Bernardo

http://www.w3.org/2001/XMLSchema#string

Maria J Merino

http://www.w3.org/2001/XMLSchema#string

Maria L Lindenberg

http://www.w3.org/2001/XMLSchema#string

Peter A Pinto

http://www.w3.org/2001/XMLSchema#string

Peter L Choyke

http://www.w3.org/2001/XMLSchema#string

Rikard Owenius

http://www.w3.org/2001/XMLSchema#string

Stephen Adler

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2012

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations

Fluorodeoxyglucose positron emission tomography studies in diagnosis and staging of clinically organ-confined prostate cancer.

Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation

Detection of recurrent prostate carcinoma with anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid PET/CT and 111In-capromab pendetide SPECT/CT

Fluorocholine PET/CT in patients with prostate cancer: initial experience.

Imaging prostate cancer: an update on positron emission tomography and magnetic resonance imaging

Imaging localized prostate cancer: current approaches and new developments.

11C-Acetate PET/CT in localized prostate cancer: a study with MRI and histopathologic correlation.

Characterization of primary prostate carcinoma by anti-1-amino-2-[(18)F] -fluorocyclobutane-1-carboxylic acid (anti-3-[(18)F] FACBC) uptake

P304

849-856

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1148/RADIOL.13130240

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

270

http://www.w3.org/2001/XMLSchema#string

P50

Karen A. Kurdziel

P577

2013-11-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259983703

http://www.w3.org/2001/XMLSchema#string

P698

24475804

http://www.w3.org/2001/XMLSchema#string

P932

4263644

http://www.w3.org/2001/XMLSchema#string